Opus Genetics Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

0.96

0.02 (2.35%)

At close: May 02, 2025, 3:59 PM

0.97

1.33%

After-hours: May 02, 2025, 04:57 PM EDT

Opus Genetics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	10.99M	8.38M	16.45M	19.01M	19.05M	57.21M	45.27M	41.6M	39.85M	n/a	489K	589K	589K	589K	100K	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	10K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	10.98M	8.38M	16.45M	19.01M	19.05M	57.21M	45.27M	41.6M	39.85M	n/a	489K	589K	589K	589K	100K	n/a	n/a	n/a	n/a	n/a
Operating Income	-62.07M	-29.47M	-15.08M	-12.14M	-10.56M	29.08M	18.15M	18.6M	18.23M	-22.13M	-21.83M	-24.03M	-22.7M	-30.58M	-28.29M	-22.42M	-19.97M	-5.95M	-4M	-2.73M
Interest Income	1.1M	1.1M	600K	600K	367K	367K	367K	367K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-57.53M	-27.19M	-14.09M	-11.29M	-9.97M	29.08M	18.97M	19.01M	18.2M	-22.37M	-22.07M	-24.27M	-56.69M	-69.06M	-66.08M	-60.55M	-24.62M	-5.94M	-4.69M	-3.09M
Net Income	-57.53M	-27.19M	-14.11M	-11.3M	-9.99M	28.75M	18.66M	18.69M	17.89M	-22.37M	-22.07M	-24.27M	-56.69M	-69.06M	-66.08M	-60.55M	-24.62M	-5.94M	-4.69M	-3.09M
Selling & General & Admin	18.21M	14.2M	13.36M	14.34M	11.96M	10.73M	10.38M	7.82M	7.27M	6.63M	6.52M	8.15M	8.12M	8.02M	6.99M	4.13M	2.82M	1.51M	942K	391K
Research & Development	26.85M	23.66M	18.17M	16.81M	17.65M	17.4M	16.74M	15.18M	14.36M	15.51M	15.8M	16.46M	15.17M	14.77M	13.03M	9.91M	6.65M	2.31M	929K	218K
Other Expenses	28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.38M	8.38M	8.38M	10.5M	2.13M	2.13M	2.13M
Operating Expenses	73.07M	37.85M	31.53M	31.15M	29.61M	28.13M	27.12M	23M	21.62M	22.13M	22.32M	24.62M	23.29M	31.17M	28.39M	22.42M	19.97M	5.95M	4M	2.73M
Interest Expense	n/a	n/a	1.33M	1.33M	1.33M	1.33M	n/a	4K	9K	11K	11K	7K	2K	5.42M	5.6M	6.29M	6.85M	1.42M	1.24M	554K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	73.07M	37.85M	31.53M	31.15M	29.61M	28.13M	27.12M	23M	21.62M	22.13M	22.32M	24.62M	23.29M	31.17M	28.39M	22.42M	19.97M	5.95M	4M	2.73M
Income Tax Expense	n/a	-2K	12K	12K	12K	329K	315K	315K	315K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	31.57M	26.15M	25.83M	24.52M	21.52M	21.45M	20.96M	20.94M	20.81M	20.5M	19.5M	18.89M	17.85M	16.93M	13.61M	10.92M	n/a	7.09M	7.09M	7.09M
Shares Outstanding (Diluted)	31.57M	26.15M	25.83M	24.52M	22M	22.41M	20.96M	20.94M	21.48M	20.5M	19.5M	18.89M	17.85M	16.93M	13.61M	10.92M	n/a	7.09M	7.09M	7.09M
EPS (Basic)	-2.21	-1.1	-0.55	-0.49	-0.48	1.37	0.89	0.88	0.81	-1.17	-1.2	-1.47	-4.69	-4.34	-4.27	-3.98	-0.85	-0.85	-0.67	-0.44
EPS (Diluted)	-2.21	-1.1	-0.56	-0.5	-0.49	1.31	0.84	0.83	0.76	-1.17	-1.2	-1.47	-4.69	-4.34	-4.27	-3.98	-0.85	-0.85	-0.67	-0.44
EBITDA	-58.69M	-28.36M	-13.93M	-10.99M	-9.41M	29.64M	18.21M	18.68M	18.22M	-22.35M	-22.05M	-24.26M	-56.69M	-63.63M	-60.47M	-54.25M	-17.77M	-4.51M	-3.44M	-2.53M
EBIT	-58.7M	-28.36M	-13.93M	-10.99M	-9.41M	29.64M	18.2M	18.67M	18.21M	-22.36M	-22.05M	-24.27M	-56.69M	-63.63M	-60.47M	-54.25M	-17.77M	-4.52M	-3.45M	-2.53M
Depreciation & Amortization	10K	3K	4K	5K	6K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	8K	7K	6K	5K